4-oxopentanal has been researched along with limonene-1,2-epoxide in 1 studies
| Studies (4-oxopentanal) | Trials (4-oxopentanal) | Recent Studies (post-2010) (4-oxopentanal) | Studies (limonene-1,2-epoxide) | Trials (limonene-1,2-epoxide) | Recent Studies (post-2010) (limonene-1,2-epoxide) |
|---|---|---|---|---|---|
| 11 | 0 | 10 | 29 | 0 | 13 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrero-Moreno, J; Coelhan, M; Leva, P; Lipsa, D | 1 |
1 other study(ies) available for 4-oxopentanal and limonene-1,2-epoxide
| Article | Year |
|---|---|
Inflammatory effects induced by selected limonene oxidation products: 4-OPA, IPOH, 4-AMCH in human bronchial (16HBE14o-) and alveolar (A549) epithelial cell lines.
Topics: Aldehydes; Bronchi; Cell Line; Cell Survival; Chemokines; Cyclohexane Monoterpenes; Cyclohexanes; Cyclohexenes; Cytokines; Dose-Response Relationship, Drug; Epithelial Cells; Humans; Inflammation; Ketones; Limonene; Monoterpenes; Oxidation-Reduction; Pulmonary Alveoli; Terpenes | 2016 |